Skip to main content
Premium Trial:

Request an Annual Quote

Yourgene: Scott Sargent

Scott Sargent has been appointed as VP of sales for North America at Yourgene. Most recently, he was director of sales for clinical genomics at Qiagen in the US and Canada. Prior to that, he held senior commercial roles at Illumina, and before that, he worked for Luminex and Roche Diagnostics. At Yourgene, he will be responsible for building a North American commercial team and will work closely with the Costal Genomics team to win new customers for the Ranger sample prep technology.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.